Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis

Annals of Allergy, Asthma and Immunology

Volumn 78, Issue 3, 1997, Pages 270-276

  Holmberg, K ^a   Juliusson, S ^a   Balder, B ^a   Smith, D L ^b   Richards, D H ^b   Karlsson, G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUTICASONE PROPIONATE; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; EOSINOPHILIA; EPISTAXIS; FEMALE; HUMAN; INTRANASAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; POLYPECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SNEEZING;

EID: 0030944557     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)63180-8     Document Type: Article

References (41)

1. Baumgarten C, Kunkel G, Rudolph R, et al. Histopathologic examinations of nasal polyps of different etiology. Arch Otolaryngol 1980;226:187-97.
2. Caplin I, Haynes TJ, Spahn J. Are nasal polyps an allergic phenomenon? Ann Allergy 1971;29:631-4.
3. Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. Br Med J 1973;4:464-6.
4. Mygind N, Pedersen CB, Prytz S, Sörensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975;5: 169-4.
5. Pedersen CB, Mygind N, Sörensen H, Prytz S. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol-clinical results. Acta Otolaryngol 1976;82:256-9.
6. Deutschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977;15:17-23.
7. Virolainen E, Puhakka H. The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 1980; 18:9-18.
8. Holopainen E, Grahne B, Malmberg H, et al. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis 1982; 63(suppl 122):22-8.
9. Drettner B, Ebbesen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982; 20:149-58.
10. Karlsson G, Rundcrantz H. A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982;20:144-8.
11. Dingsör G, Kramer J, Olsholt R, Söderström T. Flunisolide nasal spray 0.025% in the prophylactic treatment of nasal polyposis after polypectomy. A randomized, double-blind, parallel, placebo controlled study. Rhinology 1985;23:49-51.
12. Hartwig S, Linden M, Laurent C, et al. Budesonide nasal spray as prophylactic treatment after polypectomy. J Laryngol Otol 1988;102:148-51.
13. Rhuno J, Andersson B, Denburg J, et al. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis. J Allergy Clin Immunol 1990;86:946-53.
14. Johansen LV, Ilium P, Kristensen S, et al. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 1993;18:524-7.
15. Lildholt T, Rundcrantz H, Lindqvist N. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 1995;20: 26-30.
16. Lildholt T. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol (Stockh) 1988;105:140-3.
17. Mygind N. Nasal polyps. In: Mygind N, ed. Nasal allergy. London: Blackwell Scientific Publications, 1979: 233-8.
18. Drake-Lee AB. Nasal polyps. In: Macay IS, ed. Rhinitis: mechanisms and management. London: Royal Society of Medicine, 1979:141-52.
19. Tos M, Drake-Lee AB, Lund VJ, Stammberger H. Treatment of nasal polyps. Medication or surgery and with which technique. Rhinology 1989;suppl 8:45-9.
20. Mygind N. Nasal polyposis [Editorial], J Allergy Clin Immunol 1990;86: 827-9.
21. Settipane GA. Nasal polyps. In: Settipane GA, ed. Rhinitis. Rhode Island, USA, 1991: 173-83.
22. International rhinitis management working group. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49(suppl 19):1-34.
23. Holmberg K, Karlsson G. Nasal polyps: surgery or pharmacological intervention? Eur Respir Rev 1994;4: 260-5.
24. Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43: 760-75.
25. Meltzer EO, Orgel HA, Bronsky EA et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990;86:221-230.
26. Nathan RA, Bronsky EA, Fireman P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991;67:332-8.
27. Scadding GK, Lund VJ, Holmström M, Darby YC. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991; suppl 11:37-43.
28. Scadding GK, Lund VJ, Jacques A, Richards DH. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic rhinitis. Clin Exper Allergy 1995;25: 737-43.
29. Youlten LJF. The peak nasal inspiratory flow meter: a new instrument for the assessment of the response to immunotherapy in seasonal allergic rhinitis [abstract]. Allergol Immunopathol 1980;8:344.
30. Gleeson MJ, Youlten LJF, Shelton DM, et al. Assessment of nasal airway patency: a comparison of four methods. Clin Otolaryngol 1986;11: 99-107.
31. Whil J-Å, Malm L. Assessment of nasal hyperreactivity. Thesis, Malmoö, University of Lund, Sweden, 1986: 1-95.
32. Holmström M, Scadding GK, Lund VJ, Darby YC. Assessment of nasal obstruction. A comparison between rhinomanometry and nasal inspiratory peak flow. Rhinology 1990;28:191-6.
33. Fairley JW, Durham LH, Ell SR. Correlation of subjective sensation of nasal patency with nasal inspiratory peak flow rate. Clin Otolaryngol 1993;18: 19-22.
34. Sörensen H, Mygind N, Pedersen CB, Prytz S. Long-term treatment of nasal polyps with beclomethasone dipropionate aerosol. III: Morphological studies and conclusions. Acta Otolaryngol 1976;82:260-2.
35. Pipkorn U, Proud D, Lichtenstein LM, et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticoids. N Engl J Med 1987;316:1506-10.
36. Svensson C, Klementsson H, Andersson M, et al. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994;49: 177-83.
37. Lindqvist N, Holmberg K, Pipkorn U. Intranasally administered budesonide, a glucocorticoid, does not exert its clinical effect through vasoconstriction. Clin Otolaryngol 1989;14: 519-23.
38. McKenzie AW, Stoughton RB. Method for comparing percutaneous absorption of steroids. Arch Derm 1962;86:608-10.
39. Davidsson Å, Danielsen A, Viale G, et al. Positive identification in situ of m RNA expression of interleukins 6 and 12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease. Acta Otolaryngol (Stockh) [In press].
40. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990:84(Suppl. A):25-9.
41. McDowall JE. Very low systemic exposure to intranasal fluticasone propionate [abstract]. J Allergy Clin Immunol 1995;95:213.